269 related articles for article (PubMed ID: 33837406)
1. Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis.
Castañeda X; García-De-la-Mària C; Gasch O; Pericàs JM; Soy D; Cañas-Pacheco MA; Falces C; García-González J; Hernández-Meneses M; Vidal B; Almela M; Quintana E; Tolosana JM; Fuster D; Llopis J; Dahl A; Moreno A; Marco F; Miró JM;
J Antimicrob Chemother; 2021 May; 76(6):1539-1546. PubMed ID: 33837406
[TBL] [Abstract][Full Text] [Related]
2. The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.
García-de-la-Mària C; Gasch O; García-Gonzalez J; Soy D; Shaw E; Ambrosioni J; Almela M; Pericàs JM; Tellez A; Falces C; Hernandez-Meneses M; Sandoval E; Quintana E; Vidal B; Tolosana JM; Fuster D; Llopis J; Pujol M; Moreno A; Marco F; Miró JM
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610194
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination.
Cantoni L; Glauser MP; Bille J
Antimicrob Agents Chemother; 1990 Dec; 34(12):2348-53. PubMed ID: 1965105
[TBL] [Abstract][Full Text] [Related]
4. Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Marco F; de la Mària CG; Armero Y; Amat E; Soy D; Moreno A; del Río A; Almela M; Mestres CA; Gatell JM; Jiménez de Anta MT; Miró JM;
Antimicrob Agents Chemother; 2008 Jul; 52(7):2538-43. PubMed ID: 18426900
[TBL] [Abstract][Full Text] [Related]
5. Cloxacillin or fosfomycin plus daptomycin combinations are more active than cloxacillin monotherapy or combined with gentamicin against MSSA in a rabbit model of experimental endocarditis.
García-de-la-Mària C; Gasch O; Castañeda X; García-González J; Soy D; Cañas MA; Ambrosioni J; Almela M; Pericàs JM; Téllez A; Falces C; Hernández-Meneses M; Sandoval E; Quintana E; Vidal B; Tolosana JM; Fuster D; Llopis J; Moreno A; Marco F; Miró JM;
J Antimicrob Chemother; 2020 Dec; 75(12):3586-3592. PubMed ID: 32853336
[TBL] [Abstract][Full Text] [Related]
6. Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Fernandez J; Abbanat D; Shang W; He W; Amsler K; Hastings J; Queenan AM; Melton JL; Barron AM; Flamm RK; Lynch AS
Antimicrob Agents Chemother; 2012 Mar; 56(3):1476-84. PubMed ID: 22232278
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
Werth BJ; Barber KE; Ireland CE; Rybak MJ
Antimicrob Agents Chemother; 2014 Jun; 58(6):3177-81. PubMed ID: 24663016
[TBL] [Abstract][Full Text] [Related]
8. Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus.
Xiong YQ; Hady WA; Bayer AS; Chen L; Kreiswirth BN; Yang SJ
Antimicrob Agents Chemother; 2012 Nov; 56(11):5528-33. PubMed ID: 22890759
[TBL] [Abstract][Full Text] [Related]
9. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Tsuji BT; Rybak MJ
Antimicrob Agents Chemother; 2005 Jul; 49(7):2735-45. PubMed ID: 15980344
[TBL] [Abstract][Full Text] [Related]
10. Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Miró JM; García-de-la-Mària C; Armero Y; Soy D; Moreno A; del Río A; Almela M; Sarasa M; Mestres CA; Gatell JM; Jiménez de Anta MT; Marco F;
Antimicrob Agents Chemother; 2009 Oct; 53(10):4172-7. PubMed ID: 19620326
[TBL] [Abstract][Full Text] [Related]
11. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
LaPlante KL; Rybak MJ
Antimicrob Agents Chemother; 2004 Dec; 48(12):4665-72. PubMed ID: 15561842
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Akins RL; Rybak MJ
Antimicrob Agents Chemother; 2001 Feb; 45(2):454-9. PubMed ID: 11158740
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of daptomycin and comparator agents against Staphylococcus aureus isolates from intravenous drug users with right endocarditis.
Sanchez-Porto A; Casanova-Roman M; Casas-Ciria J; Santaella MJ; Sanchez-Morenilla I; Eiros-Bouza JM
Infez Med; 2010 Jun; 18(2):108-12. PubMed ID: 20610933
[TBL] [Abstract][Full Text] [Related]
14. Emerging issues on
García de la Mària C; Cañas MA; Fernández-Pittol M; Dahl A; García-González J; Hernández-Meneses M; Cuervo G; Moreno A; Miró JM; Marco F
Expert Rev Anti Infect Ther; 2023 Mar; 21(3):281-293. PubMed ID: 36744387
[TBL] [Abstract][Full Text] [Related]
15. Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.
García-de-la-Mària C; Marco F; Armero Y; Soy D; Moreno A; del Río A; Almela M; Cervera C; Ninot S; Falces C; Mestres CA; Gatell JM; Jiménez de Anta MT; Miró JM;
Antimicrob Agents Chemother; 2010 Jul; 54(7):2781-6. PubMed ID: 20421394
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Sakoulas G; Eliopoulos GM; Alder J; Eliopoulos CT
Antimicrob Agents Chemother; 2003 May; 47(5):1714-8. PubMed ID: 12709345
[TBL] [Abstract][Full Text] [Related]
17. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
Cervera C; Castañeda X; de la Maria CG; del Rio A; Moreno A; Soy D; Pericas JM; Falces C; Armero Y; Almela M; Ninot S; Pare JC; Mestres CA; Gatell JM; Marco F; Miro JM;
Clin Infect Dis; 2014 Jun; 58(12):1668-75. PubMed ID: 24647021
[TBL] [Abstract][Full Text] [Related]
18. Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis.
Fernández Guerrero ML; de Górgolas M
J Antimicrob Chemother; 2006 Nov; 58(5):1066-9. PubMed ID: 16931540
[TBL] [Abstract][Full Text] [Related]
19. Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.
del Río A; García-de-la-Mària C; Entenza JM; Gasch O; Armero Y; Soy D; Mestres CA; Pericás JM; Falces C; Ninot S; Almela M; Cervera C; Gatell JM; Moreno A; Moreillon P; Marco F; Miró JM;
Antimicrob Agents Chemother; 2016 Jan; 60(1):478-86. PubMed ID: 26525803
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Cha R; Rybak MJ
Diagn Microbiol Infect Dis; 2003 Nov; 47(3):539-46. PubMed ID: 14596973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
